Literature DB >> 15693747

Diagnosis and management of patients with bipolar II disorder.

Lakshmi N Yatham1.   

Abstract

Bipolar II disorder is frequently misdiagnosed as major depressive disorder. In particular, correct diagnosis of bipolar II disorder may be delayed by years due to the predominance of depressive symptoms and the relative subtlety of hypomania, which may manifest only briefly and without elevated mood. The prevalence of bipolar II disorder varies from 0.5% to about 5% depending on the criteria used. Diagnosis can be improved by using mood disorder questionnaires, systematic probing, and prospective mood diary charting. There is a dearth of research into treatment of bipolar disorder. The limited available evidence suggests that lithium and lamotrigine may have efficacy in preventing relapse of mood episodes. Acute bipolar II depression could be treated with a combination of a mood stabilizer plus an antidepressant or pramipexole and in rare cases with antidepressant monotherapy. Hypomania will likely respond to monotherapy with antimanic agents. Adjunctive psychosocial treatments may provide additional benefit in patients with bipolar II disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15693747

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

Review 1.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

Review 2.  Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.

Authors:  Shakuntla Gondalia; Lisa Parkinson; Con Stough; Andrew Scholey
Journal:  Psychopharmacology (Berl)       Date:  2019-04-30       Impact factor: 4.530

Review 3.  Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 4.  Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 5.  A Review of 20 Years of Research on Overdiagnosis and Underdiagnosis in the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) Project.

Authors:  Mark Zimmerman
Journal:  Can J Psychiatry       Date:  2016-02       Impact factor: 4.356

6.  Characteristics of Alpha Band Frequency in Adolescents with Bipolar II Disorder: A Resting-State QEEG Study.

Authors:  Mahdi Moeini; Ali Khaleghi; Mohammad Reza Mohammadi
Journal:  Iran J Psychiatry       Date:  2015

Review 7.  The relationship between borderline personality disorder and bipolar disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Dialogues Clin Neurosci       Date:  2013-06       Impact factor: 5.986

8.  Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid.

Authors:  Alana Fisher; Rachael Keast; Daniel Costa; Louise Sharpe; Vijaya Manicavasagar; Josephine Anderson; Ilona Juraskova
Journal:  BMC Psychiatry       Date:  2020-09-17       Impact factor: 3.630

9.  Evaluation of Cerebral Cortex Function in Clients with Bipolar Mood Disorder I (BMD I) Compared With BMD II Using QEEG Analysis.

Authors:  Ali Khaleghi; Ali Sheikhani; Mohammad Reza Mohammadi; Ali Moti Nasrabadi
Journal:  Iran J Psychiatry       Date:  2015-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.